Polaryx Therapeutics, Inc. (PLYX)
NASDAQ: PLYX · Real-Time Price · USD
5.63
+0.56 (11.05%)
At close: Apr 28, 2026, 4:00 PM EDT
5.70
+0.07 (1.24%)
Pre-market: Apr 29, 2026, 8:59 AM EDT
Polaryx Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Debt / Equity Ratio | - | - | - | 0.10 |
| Net Debt / Equity Ratio | -1.13 | -1.13 | -0.98 | 0.10 |
| Quick Ratio | 8.50 | 8.50 | 15.99 | 0.00 |
| Current Ratio | 8.55 | 8.55 | 17.30 | 2.23 |
| Return on Equity (ROE) | -193.70% | -193.70% | -1013.73% | - |
| Return on Assets (ROA) | -96.12% | -96.12% | -74.36% | - |
| Return on Capital Employed (ROCE) | -171.30% | -171.30% | -92.40% | -296.10% |
| Buyback Yield / Dilution | -32.81% | -32.81% | -219.94% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.